Fluconazole-resistant Candida parapsilosis clonally related genotypes: first report proving the presence of endemic isolates harbouring the Y132F ERG11 gene substitution in Spain.

[1]  P. Escribano,et al.  Whole genome sequencing confirms Candida albicans and Candida parapsilosis microsatellite sporadic and persistent clones causing outbreaks of candidemia in neonates. , 2021, Medical Mycology.

[2]  P. Escribano,et al.  Antifungal Susceptibility Testing Identifies the Abdominal Cavity as a Source of Candida glabrata-Resistant Isolates , 2021, Antimicrobial agents and chemotherapy.

[3]  S. Arikan‐Akdagli,et al.  Species distribution, azole resistance and related molecular mechanisms in invasive Candida parapsilosis complex isolates: Increase in fluconazole resistance in 21 years , 2021, Mycoses.

[4]  M. Ilkit,et al.  Clonal Candidemia Outbreak by Candida parapsilosis Carrying Y132F in Turkey: Evolution of a Persisting Challenge , 2021, Frontiers in Cellular and Infection Microbiology.

[5]  C. H. Camargo,et al.  Environmental Clonal Spread of Azole-Resistant Candida parapsilosis with Erg11-Y132F Mutation Causing a Large Candidemia Outbreak in a Brazilian Cancer Referral Center , 2021, Journal of fungi.

[6]  D. MacCallum,et al.  General hospital outbreak of invasive candidiasis due to azole-resistant Candida parapsilosis associated with an Erg11 Y132F mutation. , 2020, Medical mycology.

[7]  P. Escribano,et al.  Isavuconazole is highly active in vitro against Candida species isolates but shows trailing effect. , 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[8]  F. Kong,et al.  Molecular Characterization of Candida parapsilosis by Microsatellite Typing and Emergence of Clonal Antifungal Drug Resistant Strains in a Multicenter Surveillance in China , 2020, Frontiers in Microbiology.

[9]  J. Meis,et al.  Prevalence and Clonal Distribution of Azole-Resistant Candida parapsilosis Isolates Causing Bloodstream Infections in a Large Italian Hospital , 2020, Frontiers in Cellular and Infection Microbiology.

[10]  M. Kostrzewa,et al.  Evaluation of Molecular Epidemiology, Clinical Characteristics, Antifungal Susceptibility Profiles, and Molecular Mechanisms of Antifungal Resistance of Iranian Candida parapsilosis Species Complex Blood Isolates , 2020, Frontiers in Cellular and Infection Microbiology.

[11]  M. Arendrup,et al.  Genotyping Reveals High Clonal Diversity and Widespread Genotypes of Candida Causing Candidemia at Distant Geographical Areas , 2020, Frontiers in Cellular and Infection Microbiology.

[12]  Philip Smith,et al.  Fluconazole‐resistant Candida parapsilosis strains with a Y132F substitution in the ERG11 gene causing invasive infections in a neonatal unit, South Africa , 2020, Mycoses.

[13]  P. Mathur,et al.  Emergence of clonal fluconazole-resistant Candida parapsilosis clinical isolates in a multicentre laboratory-based surveillance study in India , 2019, The Journal of antimicrobial chemotherapy.

[14]  M. Castanheira,et al.  Analysis of Global Antifungal Surveillance Results Reveals Predominance of Erg11 Y132F Alteration among Azole-Resistant Candida parapsilosis and Candida tropicalis and Country-Specific Isolate Dissemination. , 2019, International journal of antimicrobial agents.

[15]  C. H. Camargo,et al.  An Azole-Resistant Candida parapsilosis Outbreak: Clonal Persistence in the Intensive Care Unit of a Brazilian Teaching Hospital , 2018, Front. Microbiol..

[16]  Y. Choi,et al.  Fluconazole-Resistant Candida parapsilosis Bloodstream Isolates with Y132F Mutation in ERG11 Gene, South Korea , 2018, Emerging infectious diseases.

[17]  AsadzadehMohammad,et al.  Epidemiology and Molecular Basis of Resistance to Fluconazole Among Clinical Candida parapsilosis Isolates in Kuwait. , 2017 .

[18]  Y. Coovadia,et al.  Detection of neonatal unit clusters of Candida parapsilosis fungaemia by microsatellite genotyping: Results from laboratory‐based sentinel surveillance, South Africa, 2009‐2010 , 2017, Mycoses.

[19]  A. Colombo,et al.  Outbreak of candidemia caused by fluconazole resistant Candida parapsilosis strains in an intensive care unit , 2016, BMC Infectious Diseases.

[20]  Y. Coovadia,et al.  Emergence of azole-resistant Candida parapsilosis causing bloodstream infection: results from laboratory-based sentinel surveillance in South Africa. , 2016, The Journal of antimicrobial chemotherapy.

[21]  J. Meis,et al.  Candida parapsilosis Resistance to Fluconazole: Molecular Mechanisms and In Vivo Impact in Infected Galleria mellonella Larvae , 2015, Antimicrobial Agents and Chemotherapy.

[22]  S. Kelly,et al.  Multidrug Transporters and Alterations in Sterol Biosynthesis Contribute to Azole Antifungal Resistance in Candida parapsilosis , 2015, Antimicrobial Agents and Chemotherapy.

[23]  S. Lockhart,et al.  Molecular Mechanisms of Fluconazole Resistance in Candida parapsilosis Isolates from a U.S. Surveillance System , 2014, Antimicrobial Agents and Chemotherapy.

[24]  P. Escribano,et al.  Molecular Identification and Antifungal Susceptibility of Yeast Isolates Causing Fungemia Collected in a Population-Based Study in Spain in 2010 and 2011 , 2013, Antimicrobial Agents and Chemotherapy.

[25]  V. Leblond,et al.  Rapid Emergence of Echinocandin Resistance during Candida kefyr Fungemia Treatment with Caspofungin , 2013, Antimicrobial Agents and Chemotherapy.